Encontrados 4 documentos, a visualizar página 1 de 1
PHEOCHROMOCYTOMA AND NEUROFIBROMATOSIS 1
Introduction: Pheochromocytomas are tumours arising from chromaffin cells in the sympathetic nervous system. Clinical manifestations are protean, function of the variable secretory profile of several compounds including catecolamines, neuropeptides and other vasoactive molecules. Neurofibromatosis I (von Recklinghausen`s disease), a prevalent autosomal dominant disorder, is the most prevalent type among the neu...
Iodo e Tiróide: O que o Clínico Deve Saber
Santana Lopes, Maria; Jácome de Castro, João; Marcelino, Mafalda; Oliveira, Maria João; Carrilho, Francisco; Limbert, EdwardA Organização Mundial de Saúde considera a carência de iodo como a principal causa mundial evitável de doenças mentais e do desenvolvimento, estimando que cerca de 13% da população mundial esteja afectada por doenças causadas pela falta de iodo. O iodo é um oligoelemento necessário na síntese de hormonas tiroideias que, uma vez que não pode ser formado pelo organismo, tem de ser ingerido regularmente com a alim...
Characterization of patients with type 2 diabetes treated with vildagliptin.
Chambel, Paula; Marcelino, Mafalda; Domingues, Adreia; Vilar, Helena; Lopes, Luís; Paradinha, Manuel; Lopes, Maria Santana; Carvalho, RaquelDiabetes mellitus is a progressive disease and the rapid growth of this global prevalence has been a worldwide concern. About a third of Portuguese population has type 2 diabetes or pre-diabetes. 2 DM is associated with significant morbidity and mortality, although the treatment so far available it is a high percentage of patients who do not achieve the proposed objectives. Vildagliptin is an inhibitor of oral ...
Quality of care in diabetic outpatient clinics.
Marcelino, Mafalda; Nobre, E Lacerda; Chambel, Paula; Domingues, Andreia; da Silva, M Paes; Santos, Valentim; Vilar, Helena; Oliveira Lopes, LType 2 Diabetes Mellitus affects an increasing number of people throughout the world. Several studies have shown that it is possible to prevent and minimize type 2 diabetes complications, be it treated appropriately over time. This study aimed to determine the quality of care provided to type 2 diabetic patients in our institution, through metabolic control and risk factors evaluation. Subjects and methods: We ...
| Financiadores do RCAAP | |||||||
|
|
|
|
|
|
||